In February 2025, the National Medical Products Administration (NMPA) approved Innogens ultra-long-acting GLP-1 injection for type 2 diabetes, signaling growing government and regulatory support for GLP-1 innovation and boosting industry confidence
For some samples ZnCl 2 (1 mM) was added at the same time as Na 2 S
PS: I would love to hear your thoughts on whether data from medical toxicology and poison centers could be beneficial in generating hypotheses for target identification in drug discovery
Common side effects of Wegovy include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, upset stomach, heartburn, bloating, gas, belching, dizziness, low blood sugar (specifically in people with type 2 diabetes), and runny nose or sore throat
LifeFile Login Already a 503B Customer
One study author noted, "Understanding the potential side effects of these treatment modalities, though rare, may help individuals and their care teams weigh each treatment's risks and benefits to develop a personalized regimen" [4]